| Publications (total 16) Less... | - Blasco L et al., "In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens.", Sci Rep, 2020 Apr 28;10(1):7163
More...- Blasco L et al., "In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens.", Sci Rep, 2020 Apr 28;10(1):7163
- Fernández-García L et al., "Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System.", Antimicrob Agents Chemother, 2018 May;62(5)
- López M et al., "Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade.", Sci Rep, 2018 Feb 6;8(1):2523
- Sánchez-Encinales V et al., "Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase.", J Infect Dis, 2017 Mar 15;215(6):966-974
- López M et al., "Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme.", PLoS One, 2017;12(3):e0174454
- López M et al., "Response to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum Sensing.", Front Cell Infect Microbiol, 2017;7:143
- López M et al., "Genome Sequence of a Clinical Strain of Acinetobacter baumannii Belonging to the ST79/PFGE-HUI-1 Clone Lacking the AdeABC (Resistance-Nodulation-Cell Division-Type) Efflux Pump.", Genome Announc, 2016 Sep 8;4(5)
- López M et al., "Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010).", Genome Announc, 2016 Oct 20;4(5)
- Garnacho-Montero J et al., "Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality.", Enferm Infecc Microbiol Clin, 2016 Nov;34(9):551-558
- Fernández-Cuenca F et al., "Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps.", J Antimicrob Chemother, 2015 Dec;70(12):3222-9
- Mosqueda N et al., "Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system.", J Antimicrob Chemother, 2014 Oct;69(10):2629-33
- López-Cortés LE et al., "Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort.", J Antimicrob Chemother, 2014 Nov;69(11):3119-26
- Villar M et al., "Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.", Medicine (Baltimore), 2014 Jul;93(5):202-210
- Rumbo C et al., "Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.", Antimicrob Agents Chemother, 2013 Nov;57(11):5247-57
- Fernández-Cuenca F et al., "[In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: multicenter national study GEIH-REIPI-Ab 2010].", Enferm Infecc Microbiol Clin, 2013 Jan;31(1):4-9
- Espinal P et al., "First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.", Antimicrob Agents Chemother, 2013 Jan;57(1):589-91
Less... |